JIP
ETTX

Jaffetilchin Investment Partners’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Jaffetilchin Investment Partners’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,000
Closed -$37K – 393
2021
Q3 		$37K Hold
11,000
– – ﹤0.01% 360
2021
Q2 		$29K Hold
11,000
– – ﹤0.01% 367
2021
Q1 		$24K Hold
11,000
– – ﹤0.01% 363
2020
Q4 		$27K Buy
+11,000
New +$21.6K ﹤0.01% 273

Other funds holding ETTX

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Jaffetilchin Investment Partners's ETTX Position: Q4 2021 in Review

Jaffetilchin Investment Partners sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q4 2021, closing a stake of 11,000 shares — an estimated $37K sold.

Jaffetilchin Investment Partners first reported a position in ETTX in Q4 2020 and held it in 4 quarters. The position peaked at $37K in Q3 2021. 28 funds tracked by Wall St. Rank hold ETTX as of Q4 2021.

  • Jaffetilchin Investment Partners reported no remaining Entasis Therapeutics Holdings Inc. position as of Q4 2021 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 11,000 Entasis Therapeutics Holdings Inc. shares in Q4 2021, an estimated $37K.
  • Jaffetilchin Investment Partners first reported a position in Entasis Therapeutics Holdings Inc. in Q4 2020 and held it in 4 quarters.
  • Jaffetilchin Investment Partners's Entasis Therapeutics Holdings Inc. position peaked at $37K in Q3 2021.
  • 28 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q4 2021.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2021, filed 17 Feb 2022.